Home › Full circle: Startup scores big deal with Pfizer - and QB3 is happy
 

Keywords :   


Full circle: Startup scores big deal with Pfizer - and QB3 is happy

2014-09-22 23:25:58| Biotech - Topix.net

David Earp, a former Geron executive, started with with Circle Pharma as an advisor through at QB3 program. He became president and CEO in October 2013, overseeing the company in its collaborations with Pfizer Inc. Startup Circle Pharma Inc., a UCSF and UC Santa Cruz spinout devising ways to disrupt a wide variety of diseases from inside cells, will work with Pfizer Inc. on two drug programs.

Tags: is full big happy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05Young face paying mortgage into retirement years
13.05Universal Credit claimants must seek 18 hours work
12.05Weekly Recap: Huggies Launches Skin Essentials Diaper, P&G Recognizes Key Suppliers & More
12.05California Bill Limits Skincare Sales to Teens & Persil Rebrands
12.05Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05Glo30 Starts 2024 Strong with 60% Growth
12.05Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05L\'Oréals Brand Value Soars to $13.4 Billion
More »